Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Shifting the center of gravity for addressing the rising cancer disease burden in Africa: A rationale for African-based integrative infectious diseases and oncology research.
Breiman RF, Demetriou G, Naidu G, Papathanasopoulos MA, Ruff P, Madhi SA. Breiman RF, et al. Among authors: ruff p. PLOS Glob Public Health. 2023 May 31;3(5):e0001970. doi: 10.1371/journal.pgph.0001970. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37256858 Free PMC article. No abstract available.
The South African breast cancer and HIV outcomes study: Profiling the cancer centres and cohort characteristics, diagnostic pathways, and treatment approaches.
Mapanga W, Ayeni OA, Chen WC, Jacobson JS, Neugut AI, Ruff P, Cubasch H, O'Neil DS, Buccimazza I, Čačala S, Stopforth LW, Farrow HA, Nietz S, Phakathi B, Chirwa T, McCormack VA, Joffe M. Mapanga W, et al. Among authors: ruff p. PLOS Glob Public Health. 2023 Oct 24;3(10):e0002432. doi: 10.1371/journal.pgph.0002432. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37874786 Free PMC article.
PAM50 intrinsic subtypes, risk of recurrence score and breast cancer survival in HIV-positive and HIV-negative patients-a South African cohort study.
Phakathi B, Dix-Peek T, Van Den Berg E, Dickens C, Nietz S, Cubasch H, Joffe M, Neugut AI, Jacobson JS, Ruff P, Duarte R. Phakathi B, et al. Among authors: ruff p. Breast Cancer Res Treat. 2023 Aug;200(3):337-346. doi: 10.1007/s10549-023-06969-1. Epub 2023 Jun 2. Breast Cancer Res Treat. 2023. PMID: 37266756 Free PMC article.
FGFR2 genetic variants in women with breast cancer.
Dix-Peek T, Dickens C, Augustine TN, Phakathi BP, Van Den Berg EJ, Joffe M, Ayeni OA, Cubasch H, Nietz S, Mathew CG, Hayat M, Neugut AI, Jacobson JS, Ruff P, Duarte RAB. Dix-Peek T, et al. Among authors: ruff p. Mol Med Rep. 2023 Dec;28(6):226. doi: 10.3892/mmr.2023.13113. Epub 2023 Oct 13. Mol Med Rep. 2023. PMID: 37830168 Free PMC article.
The association of HIV status with triple-negative breast cancer in patients with breast cancer in South Africa: a cross-sectional analysis of case-only data from a prospective cohort study.
Dubner J, Neugut AI, Joffe M, O'Neil DS, Ayeni OA, Chen WC, Buccimazza I, Čačala SR, Stopforth LW, Farrow HA, Nietz S, Murugan N, Phakathi B, Jacobson JS, Crew KD, McCormack V, Ruff P, Cubasch H, Pumpalova YS. Dubner J, et al. Among authors: ruff p. Lancet Glob Health. 2024 Dec;12(12):e1993-e2002. doi: 10.1016/S2214-109X(24)00376-0. Lancet Glob Health. 2024. PMID: 39577973 Free PMC article.
Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma (KEYNOTE-555): Results from cohort B of an open-label, phase 1 study.
Cohen G, Rapoport B, Chan SW, Ruff P, Arance A, Mujika Eizmendi K, Houghton B, Brown MP, Zielinski RM, Muñoz Couselo E, Lyle M, Anderson JR, Jain L, de Alwis D, Lala M, Akala O, Chartash E, Jacobs C. Cohen G, et al. Among authors: ruff p. PLoS One. 2024 Nov 12;19(11):e0309778. doi: 10.1371/journal.pone.0309778. eCollection 2024. PLoS One. 2024. PMID: 39531423 Free PMC article. Clinical Trial.
205 results